Skip to main content
. Author manuscript; available in PMC: 2021 Feb 16.
Published in final edited form as: Leukemia. 2021 Feb 12;35(9):2563–2569. doi: 10.1038/s41375-021-01165-w

Figure 1. Mortality in the LRF CLL4 trial (n=777).

Figure 1

(A) Causes of death. * ‘Various’ included 21 cardiovascular causes and 46 other cancers. (B) Fatal infections. Note: this is a diagrammatic representation of the data. The areas of the circles correspond to the number of patients in each category, but the areas of the overlapping sections do not.